The editorial reference
for what comes after weight loss.
AfterLoss Atlas is the patient-facing editorial reference for body contouring after GLP-1 medication or bariatric surgery in 2026. Every state. Plain English. Board-certified surgeons only.
What we do
We translate the technical reality of post-weight-loss body contouring into decisions patients can act on. Body contouring is procedure-specific and patient-specific — costs depend on state and surgeon, recovery depends on which procedures are combined, candidacy depends on weight-loss method and stability, and surgeon experience varies materially by procedure type. The site is organized around five procedure hubs and 50 state guides on verifying a board-certified surgeon yourself, so you find your specific situation fast.
What we don’t do
We don’t run a surgeon directory, and we don’t list, rank, endorse, or route individual surgeons — the site is editorial guidance on verifying a surgeon yourself. We don’t accept paid placement from compounding pharmacies, telehealth brands, or device vendors. We don’t treat "board-certified in cosmetic surgery" as equivalent to ABPS board certification (those are not equivalent credentials). We don’t use AI-generated patient photos. We don’t use deepfaked before-and-afters. We don’t pretend every patient is a candidate for every procedure.
Why this matters now
In February 2026 the FDA issued Warning Letter #721455 to Medvi, a telehealth company that built roughly $401M in first-year revenue selling compounded GLP-1 medications through 800-plus AI-generated fake doctor profiles and deepfaked patient before-and-after photos. The Medvi case is the cautionary tale this site exists in deliberate contrast to. The post-weight-loss aesthetics market needs a legitimate editorial reference — one that can be cited, verified, and trusted.
The team
An iSimplifyMe publication, written and edited by The AfterLoss Atlas Editorial Team. Every page is built from primary sources — ASPS Plastic Surgery Statistics, peer-reviewed surgical journals, FDA drug labels, the ABPS public registry, CMS coverage criteria, ASA perioperative guidance — and revised by a human editor for accuracy before publication, with inline citations and a dated “last reviewed” stamp. See editorial team for the full process and AI transparency for how AI fits in our publishing workflow.
Reach us
Editorial: [email protected]
Corrections: [email protected]
Privacy: [email protected]